Pronóstico del mercado de dispositivos de neuroestimulación de Asia Pacífico hasta 2030 – Análisis regional – por producto (estimulador de la médula espinal, estimulador cerebral profundo, estimulador del nervio sacro, estimulador del nervio vago y otros), aplicación (manejo del dolor, epilepsia, incontinencia urinaria y fecal, Parkinson) s, y otros) y usuario final (hospitales, clínicas especializadas y otros)

BMIRE00030036 | Pages: 86 | Medical Device | Apr 2024 | Type: Regional | Status: Published
El mercado de dispositivos de neuroestimulación de Asia Pacífico estaba valorado en 1.197,94 millones de dólares en 2022 y se espera que alcance los 2.517,30 millones de dólares en 2030; se estima que registrará una tasa compuesta anual del 9,7% de 2022 a 2030. Los crecientes avances y aprobaciones de dispositivos de neuroestimulación impulsan el mercado de dispositivos de neuroestimulación de Asia Pacífico Los fabricantes están invirtiendo una cantidad significativa en el desarrollo de productos y tecnologías avanzados, como dispositivos de neuroestimulación implantables. Además, en el mercado de dispositivos de neuroestimulación se observa un aumento en las aprobaciones de la Administración de Alimentos y Medicamentos (FDA) para nuevos neuroestimuladores con nuevas aplicaciones. A continuación se muestran algunos avances y aprobaciones para los dispositivos de neuroestimulación. En febrero de 2021, Mainstay Medical desarrolló un sistema de neuroestimulación restaurador implantable, ReActiv8, para tratar el dolor lumbar crónico intratable. En marzo de 2021, Abbott lanzó NeuroSphere, una clínica virtual diseñada para ayudar a los pacientes de estimulación cerebral profunda a programar y restablecer sus dispositivos de forma remota desde la comodidad de sus hogares. En enero de 2021, Boston Scientific Corporation lanzó WaveWriter Alpha, una cartera de sistemas estimuladores de la médula espinal (SCS) que combinan opciones de terapia para el alivio personalizado del dolor. Por lo tanto, se espera que el creciente número de avances y aprobaciones de dispositivos de neuroestimulación brinde oportunidades lucrativas para el mercado de dispositivos de neuroestimulación durante el período de pronóstico. Descripción general del mercado de dispositivos de neuroestimulación de Asia Pacífico El mercado de dispositivos de neuroestimulación de Asia Pacífico está subsegmentado en China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico. Se espera que el mercado de Asia Pacífico sea el de más rápido crecimiento entre todas las regiones. La creciente conciencia sobre los trastornos neurológicos entre países como India, Australia y Corea del Sur define el crecimiento del mercado en la región. También se espera que crezca el mercado de dispositivos de neuroestimulación en Asia Pacífico debido al creciente desarrollo de la industria de dispositivos médicos en países como Japón y China. Además, las tendencias tecnológicas innovadoras en neurología y la rápida adopción de la inteligencia artificial (IA) y el aprendizaje automático (ML) son algunos de los factores que impulsan el mercado en la región. Además, las iniciativas gubernamentales de apoyo y la investigación en neurología también impulsan el crecimiento del mercado. Ingresos del mercado de dispositivos de neuroestimulación de Asia Pacífico y pronóstico hasta 2030 (millones de dólares estadounidenses) Segmentación del mercado de dispositivos de neuroestimulación de Asia Pacífico El mercado de dispositivos de neuroestimulación de Asia Pacífico está segmentado según el producto, la aplicación, el usuario final y el país. Según el producto, el mercado de dispositivos de neuroestimulación de Asia Pacífico se segmenta en estimulador de la médula espinal, estimulador cerebral profundo, estimulador del nervio sacro, estimulador del nervio vago y otros. El segmento de estimuladores de la médula espinal tuvo la mayor cuota de mercado en 2022. En términos de aplicación, el mercado de dispositivos de neuroestimulación de Asia Pacífico se clasifica en tratamiento del dolor, epilepsia, incontinencia urinaria y fecal, enfermedad de Parkinson y otros. El segmento de manejo del dolor tuvo la mayor participación de mercado en 2022. Por usuario final, el mercado de dispositivos de neuroestimulación de Asia Pacífico se segmenta en hospitales, clínicas especializadas y otros. El segmento de hospitales tuvo la mayor participación de mercado en 2022. Según el país, el mercado de dispositivos de neuroestimulación de Asia Pacífico está segmentado en el Reino Unido, China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico. China dominó la cuota de mercado de dispositivos de neuroestimulación de Asia Pacífico en 2022. Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc y Mainstay Medical se encuentran entre las empresas líderes que operan en el mercado de dispositivos de neuroestimulación de Asia Pacífico.
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Asia Pacific Market Analysis

5.1 Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Mainstay Medical

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 8. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Mainstay Medical

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific neurostimulation devices market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440